Discontinued — last reported Q3 '26
General Mills Total Cost of Revenue decreased by 3.1% to $3.07B in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 4.2%, from $3.20B to $3.07B. Over 4 years (FY 2021 to FY 2025), Total Cost of Revenue shows relatively stable performance with a 2.2% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase relative to revenue suggests rising production costs or margin compression, while a decrease suggests improved operational efficiency.
Total cost of revenue includes the direct costs attributable to the production of goods or the delivery of services sold...
Varies by industry; for medical device manufacturers, this includes significant manufacturing and supply chain costs.
total_cost_of_revenue| Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $2.94B | $2.94B | $3.39B | $3.13B | $3.12B | $3.27B | $3.52B | $3.46B | $3.30B | $3.13B | $3.37B | $3.39B | $3.03B | $3.16B | $3.31B | $3.20B | $3.08B | $2.98B | $3.17B | $3.07B |
| QoQ Change | — | +0.1% | +15.3% | -7.6% | -0.4% | +4.8% | +7.5% | -1.6% | -4.6% | -5.1% | +7.6% | +0.5% | -10.8% | +4.4% | +4.7% | -3.2% | -3.8% | -3.2% | +6.2% | -3.1% |
| YoY Change | — | — | — | — | +6.1% | +11.1% | +3.6% | +10.4% | +5.8% | -4.1% | -4.0% | -2.0% | -8.4% | +0.8% | -1.9% | -5.6% | +1.9% | -5.5% | -4.3% | -4.2% |